Effect of intravenous polyunsaturated phosphatidylcholine infusion on insulin receptor processing and lipid composition of erythrocytes in patients with liver cirrhosis
This 1992 study investigated whether intravenous infusion of polyunsaturated phosphatidylcholine (PPC) could improve insulin receptor processing and alter erythrocyte membrane lipid composition in patients with liver cirrhosis. Thirteen cirrhotic patients received 2 g/day of PPC for 3 days. Post-treatment assessments showed a decreased erythrocyte cholesterol-to-phospholipid molar ratio and increased polyunsaturated